Phoenix Laser Systems
This article was originally published in The Gray Sheet
Executive SummaryInvestor group led by Hong Kong businessman Sun Sun Chan files statement with the Securities and Exchange Commission opposing a proposed reorganization of Fremont, California-based Phoenix Laser Systems ("The Gray Sheet" April 12, p. 14). Phoenix subsequently filed a suit in the Superior Court of California in San Francisco on April 6 accusing Chan et al. of previous "misappropriation of funds" and of acting in accordance with a plan to "take over management and control" of the company. The charges include allegations of "engineered 'dumping' of Phoenix stock in an effort to depress stock prices and thereby pressure current management to accede to improper demands by Chan and his agents," according to an April 9 Phoenix release.
You may also be interested in...
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.
Executives On The Move: Comings And Goings At Atara Biothera And Pfizer, Along With A Promotion At Domainex
T-cell immunotherapy firm Atara Biotherapeutics decides on a chief commercial officer and Pfizer oncology R&D head leaves for CSO spot at Vividion Therapeutics. Also, COO of UK drug discovery CRO Domainex is set to climb to CEO position.